Locations:

Tag: jaroslaw maciejewski

January 15, 2020/Cancer/Research

New Clinic Tackles Mutations That Increase Risk of Blood Cancers and Heart Disease

CHIP Clinic's goals: Research, preventive care

February 21, 2019/Cancer/Blood Cancers

Three Targeted Agents in Development for Molecular Subtypes of Leukemia

Investigators making strides in cancer drug discovery

February 6, 2019/Cancer/News & Insight

Chipping Away at the Mystery of Clonal Hematopoiesis of Indeterminate Potential (CHIP)

CHIP clinic in the works

April 27, 2018/Basic & Translational Science

Mutations in Aplastic Anemia Can Predict Increased Risk of Myelodysplastic Syndromes

Not all mutations are prognosticative

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

December 11, 2017/Cancer/Research

Exploiting Vulnerability of Impaired DNA Repair Creates New Therapeutic Strategy in Acute Myeloid Leukemia

Cleveland Clinic researchers first to show sensitivity of IDH1/2 mutations to PARP inhibitor olaparib

April 24, 2017/Cancer/Blood Cancers

Dynamics of Two Mutational Paths in the Progression of MDS

Largest genomic assessment of MDS to date

March 15, 2017/Cancer/Research

Cleveland Clinic Researcher Receives $5.5 Million Outstanding Investigator Award

Maciejewski honored for work in bone marrow failure syndromes

March 28, 2016/Cancer/Genomics

A ‘Paradigm Shift’ in Conception of Aplastic Anemia

Gene mutations discovered in some patients may lead to malignancy

December 6, 2015/Cancer/Blood Cancers

Expanding Clones Seen in Minority of Patients With Aplastic Anemia Treated With Eltrombopag

Researchers suspect that mutations may be leukemogenic

January 7, 2015/Cancer/Research

Next Generation Sequencing Drives New Insights on Cancers

New information poised to individualize patient care

BackPage 1 of 1Next